Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
about
Secondary treatment of acute graft-versus-host disease: a critical reviewPathogenesis and management of graft-versus-host disease.Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases.Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)Management of acute graft-versus-host disease in children.Mycophenolate in dermatology.Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effectsAdvances in the understanding of acute graft-versus-host disease.Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.Emerging drugs for acute graft-versus-host disease.Acute graft-versus-host disease: new treatment strategies.The use of monoclonal antibodies for the treatment of graft-versus-host disease following allogeneic stem cell transplantation.Clinical tolerance in allogeneic hematopoietic stem cell transplantation.Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis.Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation.Mycophenolate use in dermatology: a clinical audit.Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease
P2860
Q26823275-F7387954-26C5-4683-BF5A-1DAF321AB8E3Q34077479-87AC6F9C-77E9-4462-A17F-A77A8AD4B0DEQ35015845-66E720DF-2F99-4C2F-8602-7ECF0F981D4DQ35174524-1284B313-A9DB-4E7B-9D01-51EC499DB0F4Q35583009-0728795A-7B29-4ECB-9828-3C6464F6BBECQ35601973-223E95CE-BA5C-43F7-8337-40E5136D111FQ35760517-F386D720-A575-44D6-9E63-82253A8DEA2CQ36380188-17A628A9-B6E5-4839-A707-52F718707DE9Q36759581-20E7EA1D-EC3F-402D-ABF7-53E757F7CC3EQ37201939-695DB1CD-CC73-43F8-9505-F11984567376Q37515433-41D26CC0-6334-48E1-BFA3-27909C03B567Q37610714-532E8B83-6C5F-42EC-AFE7-1DCAD1AD5626Q37851519-EFB5B0AC-72B2-4BA3-B81A-B692FC16EB3CQ37864697-D7FDC8C4-33D0-4371-A22C-7F326754C056Q38010596-81264855-C678-478A-BF38-D3B5B5DB0135Q44925296-3CA4530B-7300-49AB-B573-42B4A14D4AC2Q45001838-AB35F1F0-40C2-4957-8453-138C77EEAF44Q46122348-91C8D360-B7B5-46B6-83DB-0699BCEBEBABQ57252632-99223173-D8D7-4A91-B20C-FA0E81EDB362
P2860
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Mycophenolate Mofetil in the t ...... nts: four years of experience.
@en
Mycophenolate Mofetil in the t ...... nts: four years of experience.
@nl
type
label
Mycophenolate Mofetil in the t ...... nts: four years of experience.
@en
Mycophenolate Mofetil in the t ...... nts: four years of experience.
@nl
prefLabel
Mycophenolate Mofetil in the t ...... nts: four years of experience.
@en
Mycophenolate Mofetil in the t ...... nts: four years of experience.
@nl
P2093
P1476
Mycophenolate Mofetil in the t ...... nts: four years of experience.
@en
P2093
A A Fauser
B Schmetzer
M Bischoff
S Günzelmann
P304
P356
10.1016/S0041-1345(01)01968-6
P407
P577
2001-05-01T00:00:00Z